فروكوينتينيبي

Enquire Best Price to Buy Fruquintinib in India

About API Fruquintinib:

Elunate/Fruzaqla (fruquintinib) is an oral targeted therapy that selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, VEGFR-2, and VEGFR-3. By blocking these pathways, it helps suppress angiogenesis, a process that supports tumor growth and spread. The treatment is indicated for patients with previously treated metastatic colorectal cancer (mCRC), including those who have progressed after standard chemotherapy and biologic therapies. Its high receptor selectivity contributes to a favorable balance of efficacy and tolerability in later-line treatment settings.